Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Inscripta
5500 Central Avenue #220
Boulder, CO 80301
Phone: 720-759-4088
https://www.inscripta.com/

Inscripta is a gene-editing technology company that puts researchers in control by making it easy for them to get all they need for cutting-edge, forward cell-engineering. These tools include a family of CRISPR enzymes (called MADzymes), custom nucleases for researchers and commercial partners, and a full suite of gene-editing tools (instruments, reagents, and software) that will significantly increase the speed and efficiency of multiplexed, precision gene editing. By removing the barriers to forward cell engineering and gene-editing research, Inscripta will usher in a new era of advances to revolutionize how we feed, fuel, and heal humanity.

Key Contact
Name
Kevin Ness
Title
CEO
Funding Events

Date
Amount
Type
Investors
02/28/18 $55,500,000 Series C Merieux Developpement
Paladin Capital Group
04/04/19 $20,000,000 Series C Foresite Capital
Merieux Developpement
MLS Capital
NanoDimension
Paladin Capital Group
Venrock


Featured Reading